Jinfeng Zou

Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Circulating Cell-Free DNA Methylation Profiling Enables Detection, Distinction, and Estrogen Receptor Status Classification of Advanced Breast Cancer.

Circulating Cell-Free DNA Methylation Profiling Enables Detection, Distinction, and Estrogen Receptor Status Classification of Advanced Breast Cancer.

Journal: Cancer research

Published: January 06, 2026

HPV Serology and Circulating Viral DNA for Detection, Genotyping, and Measurement of Disease Burden in Oropharyngeal Cancer.

HPV Serology and Circulating Viral DNA for Detection, Genotyping, and Measurement of Disease Burden in Oropharyngeal Cancer.

Journal: International journal of cancer

Published: October 27, 2025

Circulating human papillomavirus DNA sequencing as a biomarker of response in advanced cervical cancer.

Circulating human papillomavirus DNA sequencing as a biomarker of response in advanced cervical cancer.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: December 02, 2024

Multimodal detection of molecular residual disease in high-risk locally advanced squamous cell carcinoma of the head and neck.

Multimodal detection of molecular residual disease in high-risk locally advanced squamous cell carcinoma of the head and neck.

Journal: Cell death and differentiation

Published: December 03, 2023

Clinical Validation of Human Papilloma Virus Circulating Tumor DNA for Early Detection of Residual Disease After Chemoradiation in Cervical Cancer.

Clinical Validation of Human Papilloma Virus Circulating Tumor DNA for Early Detection of Residual Disease After Chemoradiation in Cervical Cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: November 16, 2023

Exclusion of persistent mutations in splicing factor genes and isocitrate dehydrogenase 2 improves the prognostic power of molecular measurable residual disease assessment in acute myeloid leukemia.

Exclusion of persistent mutations in splicing factor genes and isocitrate dehydrogenase 2 improves the prognostic power of molecular measurable residual disease assessment in acute myeloid leukemia.

Journal: Haematologica

Published: May 10, 2023

Circulating tumour DNA kinetics in recurrent/metastatic head and neck squamous cell cancer patients.

Circulating tumour DNA kinetics in recurrent/metastatic head and neck squamous cell cancer patients.

Journal: European journal of cancer (Oxford, England : 1990)

Published: March 10, 2023

Tumor-Naïve Multimodal Profiling of Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma.

Tumor-Naïve Multimodal Profiling of Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: January 10, 2021

Association of Germline Variants in Natural Killer Cells With Tumor Immune Microenvironment Subtypes, Tumor-Infiltrating Lymphocytes, Immunotherapy Response, Clinical Outcomes, and Cancer Risk.

Association of Germline Variants in Natural Killer Cells With Tumor Immune Microenvironment Subtypes, Tumor-Infiltrating Lymphocytes, Immunotherapy Response, Clinical Outcomes, and Cancer Risk.

Journal: JAMA network open

Published: September 05, 2019

HPV Sequencing Facilitates Ultrasensitive Detection of HPV Circulating Tumor DNA.

HPV Sequencing Facilitates Ultrasensitive Detection of HPV Circulating Tumor DNA.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: July 22, 2019

Impact of preleukemic mutations and their persistence on hematologic recovery after induction chemotherapy for AML.

Impact of preleukemic mutations and their persistence on hematologic recovery after induction chemotherapy for AML.

Journal: Blood advances

Published: April 15, 2019

Germline variants associated with leukocyte genes predict tumor recurrence in breast cancer patients.

Germline variants associated with leukocyte genes predict tumor recurrence in breast cancer patients.

Journal: NPJ precision oncology

Published: March 23, 2019

Showing 1-12 of 24

Last Updated: 09/26/2026